Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2012 4
2013 2
2017 1
2020 1
2021 6
2022 9
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Is MS affecting the CNS only? Lessons from clinic to myelin pathophysiology.
Oudejans E, Luchicchi A, Strijbis EMM, Geurts JJG, van Dam AM. Oudejans E, et al. Among authors: strijbis emm. Neurol Neuroimmunol Neuroinflamm. 2020 Nov 24;8(1):e914. doi: 10.1212/NXI.0000000000000914. Print 2021 Jan. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 33234720 Free PMC article. Review.
Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis.
Broos JY, Loonstra FC, de Ruiter LRJ, Gouda M, Fung WH, Schoonheim MM, Heijink M, Strijbis EMM, Teunissen C, Killestein J, de Vries HE, Giera M, Uitdehaag BMJ, Kooij G. Broos JY, et al. Among authors: strijbis emm. Neurology. 2023 Aug 1;101(5):e533-e545. doi: 10.1212/WNL.0000000000207459. Epub 2023 Jun 8. Neurology. 2023. PMID: 37290971 Free PMC article.
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis.
Toorop AA, van Kempen ZLE, Steenhuis M, Nielsen J, Sinnige LGF, van Dijk G, Roosendaal CM, Arnoldus EPJ, Hoitsma E, Lissenberg-Witte BI, de Jong BA, Oosten BWV, Strijbis EMM, Uitdehaag BMJ, Rispens T, Killestein J; NEXT-MS study group. Toorop AA, et al. Among authors: strijbis emm. J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):482-486. doi: 10.1136/jnnp-2022-330467. Epub 2023 Jan 13. J Neurol Neurosurg Psychiatry. 2023. PMID: 36639226
The role of CD56bright NK cells in neurodegenerative disorders.
Rodriguez-Mogeda C, van Ansenwoude CMJ, van der Molen L, Strijbis EMM, Mebius RE, de Vries HE. Rodriguez-Mogeda C, et al. Among authors: strijbis emm. J Neuroinflammation. 2024 Feb 13;21(1):48. doi: 10.1186/s12974-024-03040-8. J Neuroinflammation. 2024. PMID: 38350967 Free PMC article. Review.
Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis.
Loonstra FC, de Ruiter LRJ, Koel-Simmelink MJA, Schoonheim MM, Strijbis EMM, Moraal B, Barkhof F, Uitdehaag BMJ, Teunissen C, Killestein J. Loonstra FC, et al. Among authors: strijbis emm. Neurol Neuroimmunol Neuroinflamm. 2022 Dec 21;10(2):e200078. doi: 10.1212/NXI.0000000000200078. Print 2023 Mar. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36543540 Free PMC article.
30 results